A number of miRNAs have been shown to have roles in regulating AD associated proteins, targeting processes that contribute to β-amyloid production (e.g., BACE1 and APP), TAU phosphorylation and mitochondrial dysfunction (reviewed in [17,18]). Here, APP is linked to Alzheimer disease.